CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive devices for long term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient's native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. CircuLite's platform of PCS devices is lead by the Synergy® Pocket Micro-Pump, the world's smallest implantable blood pump, currently in a CE Mark clinical trial. Next-generation Synergy micro-pumps include an endovascular system, a fully-implantable system with physiological feedback, a right heart support system and a pediatric system.

Download JACC Article
Download Medtech Ventures article